In Competition Law and Policy Debate, Raphaël De Coninck highlights the European Commission’s recent interest in assessing the impact of pharmaceutical mergers on innovation. The article discusses the Commission’s approach and argues in favor of developing a consistent framework for assessing the impact of mergers on innovations. To read more, click the link below.
Antitrust issues in e-commerce
Furthermore, the growth of technology has significantly affected antitrust and competition analysis. The importance of innovation, the dynamic nature of the...